Imad Ajjawi
Corporate Officer/Principal presso ABSCI CORPORATION
Posizioni attive di Imad Ajjawi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ABSCI CORPORATION | Corporate Officer/Principal | 01/01/2021 | - |
Denovium, Inc.
 Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Fondatore | - | - |
| Corporate Officer/Principal | 01/08/2018 | - |
Storia della carriera di Imad Ajjawi
Formazione di Imad Ajjawi
| University of California San Diego | Masters Business Admin |
| University of Nevada | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Masters Business Admin | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 2 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABSCI CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Denovium, Inc.
Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million. | Technology Services |
- Borsa valori
- Insiders
- Imad Ajjawi
- Esperienza